Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy

• Status: Recruiting
• Trial end date: 2022-12-11
• Target enrollment: 0
• Participant gender: All

Summary

propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sherief Abd-Elsalam
• Treatments: Midazolam; Propofol

Criteria

Inclusion Criteria:

• Liver cirrhosis

• presented to colonoscopy

Exclusion Criteria:

• Encephalopathy

• Hypersensitivity

• Coagulopathy